MRM Health receives US FDA IND clearance to initiate phase 2b trial of MH002 in mild-to-moderate ulcerative colitis: Ghent, Belgium Saturday, January 10, 2026, 16:00 Hrs [IST] MRM ...

Phase 1b interim results of zumilokibart (APG777) in asthma demonstrated rapid and durable suppression of FeNO (key biomarker of Type 2 ...

Apogee Therapeutics reports early trial data showing its asthma drug APG777 sharply reduced a key inflammation marker for up ...

Dr Srinivas Rao, Co-Founder and Chief Executive Officer of AtaiBeckley, said: “Following the strategic combination of atai Life Sciences and Beckley Psytech completed last year and the recent ...

MH002 is currently the most advanced Live Biotherapeutic Product (LBP) based on a rationally-designed combination of disease specific bacteria (microbial consortia), for the treatment of inflammatory ...

China dominates and weaponises rare earth supply chain. India’s EV ecosystem can be insulated from it through carefully ...

Data readouts planned for CLN-978 across all three autoimmune indications in 2026, including single dose and repeat dosing dataCompany to ...

Construction on the Nason Basin to Grove Avenue Phase One project is expected to last until the end of January in. The Vine ...

AtaiBeckley Inc (NASDAQ: ATAI) (“AtaiBeckley” or the “Company”), a clinical-stage biotechnology company on a mission to transform patient outcomes by developing effective, rapid-acting and convenient ...

Having booked a place in the Round of 16 of the 2025-26 Copa del Rey last month, Barcelona have now learned who their ...

MoonLake requested a Type B meeting with the U.S. Food and Drug Administration (FDA) to obtain regulatory clarity and discuss the clinical evidence strategy for submission of a Biologic License ...